Glatiramer Acetate-associated Refractory Immune Thrombocytopenic Purpura
Data(s) |
2016
|
---|---|
Resumo |
We present a case of glatiramer acetate-associated refractory immune thrombocytopenic purpura (ITP) in a female patient with multiple sclerosis. A search of MEDLINE/PubMed did not find any connection between glatiramer acetate and thrombocytopenia, specifically ITP. The autoimmune reaction was resistant to conservative ITP treatment, and was eventually managed only by splenectomy. To the best of our knowledge, this is the first report of glatiramer acetate-associated ITP. Physicians should be aware of this condition, and consider performing routine blood counts at the beginning of glatiramer acetate treatment. |
Formato |
text |
Identificador |
http://eprints.bice.rm.cnr.it/15143/1/399-2668-1-PB.pdf Sagy, Iftach and Shalev, Leah and Levi, Itai and Shleyfer, Elena and Valdman, Svetlana and Barski, Leonid (2016) Glatiramer Acetate-associated Refractory Immune Thrombocytopenic Purpura. European Journal of Case Reports in Internal Medicine, 3 (3). pp. 1-3. ISSN 2284-2594 |
Idioma(s) |
en |
Publicador |
SMC media |
Relação |
http://eprints.bice.rm.cnr.it/15143/ http://ejcrim.com/index.php/EJCRIM/article/view/399 10.12890/2016_000399 |
Palavras-Chave | #616 Malattie (classificare qui la Clinica medica, la medicina basata sull'evidenza, la Medicina interna, la Medicina sperimentale) |
Tipo |
Article PeerReviewed |